5 Stocks Under $10 Set to Soar
MEI Pharma
Another under-$10 name that's trending very close to triggering a major breakout trade is MEI Pharma (MEIP), which is developing cancer therapeutics based on the central design of naturally occurring compounds called isoflavones. This stock has been on fire during the last six months, with shares up a whopping 227%.
If you take a look at the chart for MEI Pharma, you'll notice that this stock formed a double bottom at around $4.36 to $4.50 a share earlier this month. After marking that bottom, shares of MEIP have soared and moved back above its 50-day moving average with heavy upside volume flows. That move has now pushed shares of MEIP within range of triggering a major breakout trade.
Traders should now look for long-biased trades in MEIP if it manages to break out above some key overhead resistance at $7.70 a share with high volume. Look for a sustained move or close above $7.70 a share with volume that registers near or above its three-month average volume of 72,208 shares. If that breakout triggers soon, then MEIP will set up to re-test or possibly take out its next major overhead resistance levels at $10.08 to around $13 a share. Any high-volume move above $13.20 would then send shares of MEIP into new 52-week high territory, which is bullish technical price action.
Traders can look to buy MEIP off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average of $6.55 a share or around $6 a share. One could also buy MEIP off strength once it clears $7.70 a share with volume and simply use a stop that sits right around its 50-day moving average of $6.55 a share. This stock has very explosive upside potential if that breakout triggers soon, since its tradable float is just 1.47 million shares. A low-float name like this can move to the upside very quickly if buyers move into the stock with force, since the supply of actual stock to trade is so small.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV